quick search
Today:
Home AI

More Articles

Chance Pharma Secures New Funding to Accelerate Development of Innovative Inhalation Therapies

Mar 18, 2025

HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to

NYSE Content advisory: Pre-market update + Federal Reserve to Meet

Mar 18, 2025

NEW YORK,March 17,2025-- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insights before

ekko and Optty partner to make sustainable payments a global standard

Mar 18, 2025

SINGAPORE,March 18,2025-- Optty,a B Corp-certified global payments infrastructure platform,and ekko,a sustainability platform for banks and payments companies,are partnering to make it easier for bus

Yuewen Global IP Awards Creator Forum: The Rise of China's Global IP Ecosystem

Mar 5, 2025

SINGAPORE,March 3,2025-- As a pivotal component of the "2024 Yuewen Global IP Awards",the "Yuewen Global IP Awards Creator Forum" was grandly held at Resorts World Sentosa in Singa

MUST Launches New Generation of Energy Storage Product Matrix: Multi-Machine Parallel and Intelligent Management Drive Global Residential Energy Storage Upgrade

Mar 5, 2025

SHENZHEN,China,March 3,2025-- MUST,a leading solar storage solutions company,announces the launch of a new energy storage product matrix in Pakistan and Latin America. With modular expansion and intel

HONOR Introduced Four AI Technologies at MWC 2025

Mar 5, 2025

BARCELONA,Spain,March 3,2025-- Global technology brand HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device eco

Raziel and Fosun Pharma (by JuveStar an affiliate company of Fosun Pharma) Initiate Phase 3 Registration Trial in China for Submental Fat Reduction ("double chin")

Mar 5, 2025

REROVOT,Israel,March 4,2025-- Raziel Therapeutics,a pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market,announces phase 3 study initiation i

Ping An Enhances Recruitment Experience with "Ping An Talent" AI System

Mar 5, 2025

HONG KONG and SHANGHAI,March 4,2025--Ping An Insurance (Group) Company of China,Ltd. (hereafter "Ping An","the Company"or the "Group"HKEX: 2318 / 82318; SSE: 601318) rece

IRCAI and AWS Expand the Compute for Climate Fellowship Program and Opens Applications for 2025

Mar 5, 2025

The program funds proof of concepts for new ideas leveraging advanced cloud computing,including generative AI,to solve some of the biggest challenges in the fight against climate change

CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with Autoimmune Disease

Feb 28, 2025

SHANGHAI,Feb. 28,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

1 2 3 4 ... 128

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs